These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23549425)

  • 1. Poly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes.
    Long CA; Boulom V; Albadawi H; Tsai S; Yoo HJ; Oklu R; Goldman MH; Watkins MT
    Ann Surg; 2013 Dec; 258(6):1087-95. PubMed ID: 23549425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model.
    Crawford RS; Albadawi H; Atkins MD; Jones JE; Yoo HJ; Conrad MF; Austen WG; Watkins MT
    Surgery; 2010 Jul; 148(1):110-8. PubMed ID: 20132957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyadenosine diphosphate-ribose polymerase inhibition modulates skeletal muscle injury following ischemia reperfusion.
    Hua HT; Albadawi H; Entabi F; Conrad M; Stoner MC; Meriam BT; Sroufe R; Houser S; Lamuraglia GM; Watkins MT
    Arch Surg; 2005 Apr; 140(4):344-51; discussion 351-2. PubMed ID: 15837884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.
    Black JH; Casey PJ; Albadawi H; Cambria RP; Watkins MT
    J Am Coll Surg; 2006 Jul; 203(1):44-53. PubMed ID: 16798486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local administration of the Poly ADP-Ribose Polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury.
    Conrad MF; Albadawi H; Stone DH; Crawford RS; Entabi F; Watkins MT
    J Surg Res; 2006 Oct; 135(2):233-7. PubMed ID: 16872633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates renal injury after thoracic aortic ischemia/reperfusion.
    Stone DH; Al-Badawi H; Conrad MF; Stoner MC; Entabi F; Cambria RP; Watkins MT
    Surgery; 2005 Aug; 138(2):368-74. PubMed ID: 16153449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) Polymerase (PARP) is Critically Involved in Liver Ischemia/Reperfusion-injury.
    Haga S; Kanno A; Morita N; Jin S; Matoba K; Ozawa T; Ozaki M
    J Surg Res; 2022 Feb; 270():124-138. PubMed ID: 34656890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct.
    Szepes M; Janicsek Z; Benkő Z; Cselenyák A; Kiss L
    Int J Mol Med; 2013 Jan; 31(1):26-32. PubMed ID: 23165319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(adenosine diphosphate ribose) polymerase inhibition modulates spinal cord dysfunction after thoracoabdominal aortic ischemia-reperfusion.
    Casey PJ; Black JH; Szabo C; Frosch M; Albadawi H; Chen M; Cambria RP; Watkins MT
    J Vasc Surg; 2005 Jan; 41(1):99-107. PubMed ID: 15696051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP inhibitor PJ34 ameliorates cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory effects in a rat model.
    Jiao Y; Li G
    Neurosci Lett; 2021 Nov; 764():136202. PubMed ID: 34478817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced hind limb ischemia-reperfusion injury in Toll-like receptor-4 mutant mice is associated with decreased neutrophil extracellular traps.
    Oklu R; Albadawi H; Jones JE; Yoo HJ; Watkins MT
    J Vasc Surg; 2013 Dec; 58(6):1627-36. PubMed ID: 23683381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of poly(ADP-ribose) polymerase attenuates lung tissue damage after hind limb ischemia-reperfusion in rats.
    Koksel O; Yildirim C; Cinel L; Tamer L; Ozdulger A; Bastürk M; Degirmenci U; Kanik A; Cinel I
    Pharmacol Res; 2005 May; 51(5):453-62. PubMed ID: 15749460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARP-1 inhibitor alleviates cerebral ischemia/reperfusion injury by reducing PARylation of HK-1 and LDH in mice.
    Chen YL; Wang Y; Fang QY; Wang T; Chen C; Gao TY; Wu M; Zhang WP; Lu YB
    Eur J Pharmacol; 2024 Mar; 967():176377. PubMed ID: 38346469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates visceral mitochondrial activity and CD14 expression following thoracic aortic ischemia-reperfusion.
    Stone DH; Albadawi H; Conrad MF; Entabi F; Stoner MC; Casey PJ; Cambria RP; Watkins MT
    Am J Surg; 2009 Aug; 198(2):250-5. PubMed ID: 19268911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The poly(adenosine diphosphate-ribose) polymerase inhibitor PJ34 reduces pulmonary ischemia-reperfusion injury in rats.
    Hatachi G; Tsuchiya T; Miyazaki T; Matsumoto K; Yamasaki N; Okita N; Nanashima A; Higami Y; Nagayasu T
    Transplantation; 2014 Sep; 98(6):618-24. PubMed ID: 25221900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.
    Tao X; Chen X; Hou Z; Hao S; Liu B
    World Neurosurg; 2017 Nov; 107():888-899. PubMed ID: 28642177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation.
    Szabó G; Bährle S; Stumpf N; Sonnenberg K; Szabó E E; Pacher P; Csont T; Schulz R; Dengler TJ; Liaudet L; Jagtap PG; Southan GJ; Vahl CF; Hagl S; Szabó C
    Circ Res; 2002 Jan; 90(1):100-6. PubMed ID: 11786525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase.
    Szabados E; Literati-Nagy P; Farkas B; Sumegi B
    Biochem Pharmacol; 2000 Apr; 59(8):937-45. PubMed ID: 10692558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis.
    Zhou X; Patel D; Sen S; Shanmugam V; Sidawy A; Mishra L; Nguyen BN
    J Vasc Surg; 2017 Apr; 65(4):1161-1169. PubMed ID: 27288104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
    Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.